14:00 EST Anixa could begin human testing for ovarian cancer vaccine by 2025, CEO says
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ANIX:
- Anixa Biosciences’ breast cancer vaccine shows positive Phase 1 results
- Anixa Biosciences announces European patent on ovarian cancer vaccine technology
Questions or Comments about the article? Write to editor@tipranks.com